Are there health issues with a low LDL/HDL ratio?

A low LDL/HDL ratio is generally considered protective against cardiovascular disease, but extremely low ratios may indicate underlying health issues. While ratios below 2.5 are typically beneficial, very low ratios warrant investigation for conditions affecting cholesterol metabolism.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the LDL/HDL Ratio

The LDL/HDL ratio is a valuable metric for assessing cardiovascular health that compares your levels of low-density lipoprotein (LDL) cholesterol to high-density lipoprotein (HDL) cholesterol. This ratio provides insight into your cholesterol balance and helps predict cardiovascular disease risk more accurately than looking at individual cholesterol values alone.

LDL cholesterol, often called "bad" cholesterol, transports cholesterol to your arteries where it can accumulate and form plaques. HDL cholesterol, known as "good" cholesterol, helps remove excess cholesterol from your bloodstream and transport it to your liver for disposal. The ratio between these two types of cholesterol offers a snapshot of your cardiovascular risk profile.

To calculate your LDL/HDL ratio, simply divide your LDL cholesterol level by your HDL cholesterol level. For example, if your LDL is 100 mg/dL and your HDL is 50 mg/dL, your ratio would be 2.0. Understanding this ratio helps you and your healthcare provider make informed decisions about your heart health.

LDL/HDL Ratio Categories and Cardiovascular Risk

Ratio RangeRisk CategoryInterpretationAction Needed
Below 1.0< 1.0Very LowUncommon; may indicate genetic factorsEvaluate for underlying conditions
1.0-2.51.0-2.5OptimalExcellent cardiovascular protectionMaintain healthy lifestyle
2.5-3.52.5-3.5GoodLow cardiovascular riskContinue preventive measures
3.5-5.03.5-5.0BorderlineModerate riskImplement lifestyle changes
Above 5.0> 5.0High RiskElevated cardiovascular riskAggressive intervention needed

LDL/HDL ratios should be interpreted alongside other cardiovascular risk factors and clinical context.

What Constitutes a Low LDL/HDL Ratio?

A low LDL/HDL ratio typically indicates a favorable cardiovascular risk profile. Most health experts consider ratios below 2.5 to be optimal, with lower ratios generally associated with reduced cardiovascular disease risk. However, extremely low ratios, particularly those below 1.0, are less common and may warrant further investigation.

The ideal LDL/HDL ratio varies slightly based on individual risk factors, but general guidelines suggest:

  • Optimal: Less than 2.5
  • Good: 2.5 to 3.5
  • Borderline: 3.5 to 5.0
  • Poor: Above 5.0

While lower ratios are generally better, extremely low ratios (below 1.0) are uncommon and may indicate either exceptionally high HDL levels, unusually low LDL levels, or both. These scenarios, while often protective, can sometimes signal underlying metabolic or genetic conditions that deserve attention.

Benefits of a Low LDL/HDL Ratio

A low LDL/HDL ratio offers numerous cardiovascular benefits. Research consistently shows that individuals with lower ratios have significantly reduced risks of heart disease, stroke, and other cardiovascular events. This protective effect stems from the favorable balance between cholesterol delivery and removal in your bloodstream.

Studies have demonstrated that for every 1.0 decrease in the LDL/HDL ratio, there's an associated 20-30% reduction in cardiovascular disease risk. This relationship remains consistent across different populations and age groups, making the ratio a reliable predictor of heart health outcomes.

Beyond cardiovascular protection, a low LDL/HDL ratio often correlates with other positive health markers, including better insulin sensitivity, reduced inflammation, and improved endothelial function. These benefits create a cascade of positive effects throughout your body, supporting overall metabolic health and longevity. Regular monitoring of your cholesterol levels and ratios can help you track these improvements over time.

When a Low Ratio Might Signal Concerns

While a low LDL/HDL ratio is generally positive, extremely low ratios can occasionally indicate underlying health issues that require investigation. These situations are relatively rare but important to recognize, as they may reflect genetic variations, metabolic disorders, or other health conditions affecting cholesterol metabolism.

Genetic Factors and Hyperalphalipoproteinemia

Some individuals have genetic variants that cause exceptionally high HDL levels, a condition called hyperalphalipoproteinemia. While high HDL is typically protective, extremely elevated levels (above 100 mg/dL) may not provide additional cardiovascular benefits and could indicate dysfunctional HDL particles that don't effectively remove cholesterol from arteries.

Genetic conditions like CETP deficiency can cause HDL levels to exceed 150 mg/dL, creating very low LDL/HDL ratios. While these individuals often have reduced cardiovascular risk, the relationship between extremely high HDL and heart health becomes more complex at these levels, requiring specialized evaluation.

Hypobetalipoproteinemia and Low LDL Concerns

Extremely low LDL levels (below 40 mg/dL) can result from hypobetalipoproteinemia, a condition affecting the body's ability to produce or process lipoproteins. While low LDL typically reduces cardiovascular risk, very low levels may impair fat-soluble vitamin absorption and hormone production, potentially leading to deficiencies in vitamins A, D, E, and K.

Individuals with hypobetalipoproteinemia may experience symptoms including fatty liver disease, neurological problems, and growth issues in children. These complications highlight why extremely low LDL levels, despite creating favorable ratios, require medical evaluation to ensure proper nutritional status and metabolic function.

Secondary Causes of Abnormal Ratios

Various medical conditions and medications can artificially lower the LDL/HDL ratio. Hyperthyroidism, liver disease, malnutrition, and certain cancers can dramatically alter cholesterol levels. Additionally, some medications, including high-dose niacin or fibrates, can significantly raise HDL or lower LDL, creating unusually low ratios that may not reflect true cardiovascular protection.

Monitoring and Testing Your Cholesterol Levels

Regular cholesterol monitoring is essential for understanding your cardiovascular risk and tracking the effectiveness of lifestyle interventions or treatments. Traditional lipid panels measure total cholesterol, LDL, HDL, and triglycerides, providing the basic information needed to calculate your LDL/HDL ratio.

However, advanced lipid testing offers deeper insights into your cardiovascular risk. Tests measuring apolipoprotein B (ApoB) and apolipoprotein A1 (ApoA1) provide more accurate assessments of atherogenic particle numbers and HDL functionality. The ApoB/ApoA1 ratio often predicts cardiovascular risk more accurately than the traditional LDL/HDL ratio.

For comprehensive cardiovascular risk assessment, consider testing that includes advanced markers like lipoprotein(a), high-sensitivity C-reactive protein (hs-CRP), and homocysteine. These additional biomarkers provide context for interpreting your cholesterol ratios and help identify hidden risk factors that standard lipid panels might miss.

Optimizing Your LDL/HDL Ratio Naturally

Achieving and maintaining an optimal LDL/HDL ratio involves lifestyle strategies that simultaneously lower LDL and raise HDL cholesterol. These interventions not only improve your ratio but also enhance overall metabolic health and reduce inflammation throughout your body.

Dietary Strategies for Ratio Improvement

Diet plays a crucial role in optimizing your cholesterol ratio. Focus on consuming whole, unprocessed foods rich in soluble fiber, which helps lower LDL cholesterol. Include foods like oats, beans, lentils, apples, and barley in your daily meals. These foods bind to cholesterol in your digestive system, preventing its absorption.

Incorporate healthy fats from sources like olive oil, avocados, nuts, and fatty fish. These foods contain monounsaturated and omega-3 fatty acids that can raise HDL while lowering LDL cholesterol. Aim to replace saturated fats with these healthier options, and eliminate trans fats entirely from your diet.

Exercise and Physical Activity Benefits

Regular physical activity is one of the most effective ways to improve your LDL/HDL ratio. Aerobic exercise, such as brisk walking, running, cycling, or swimming, can increase HDL cholesterol by 5-10% while modestly reducing LDL levels. Aim for at least 150 minutes of moderate-intensity exercise weekly.

Resistance training also contributes to cholesterol optimization by improving insulin sensitivity and metabolic function. Combining aerobic and resistance exercises provides synergistic benefits for your cholesterol profile and overall cardiovascular health.

Lifestyle Factors Beyond Diet and Exercise

Several other lifestyle factors significantly impact your cholesterol ratio. Maintaining a healthy weight reduces LDL production and increases HDL levels. Even modest weight loss of 5-10% can improve your ratio substantially. Additionally, quitting smoking can increase HDL cholesterol by up to 10% while reducing overall cardiovascular risk.

Moderate alcohol consumption (one drink daily for women, two for men) may slightly raise HDL levels, but the risks often outweigh benefits. Managing stress through meditation, yoga, or other relaxation techniques can also positively influence your cholesterol profile by reducing inflammation and improving metabolic function.

Making Sense of Your Cholesterol Numbers

Understanding your cholesterol levels in context is crucial for making informed health decisions. While the LDL/HDL ratio provides valuable information, it should be interpreted alongside other cardiovascular risk factors including age, blood pressure, smoking status, family history, and the presence of diabetes or metabolic syndrome.

For most people, a low LDL/HDL ratio represents excellent cardiovascular health and reduced disease risk. However, if your ratio is extremely low due to very high HDL or very low LDL levels, discussing these results with your healthcare provider ensures you're not overlooking any underlying conditions that might require attention.

Regular monitoring allows you to track changes over time and assess the effectiveness of your health interventions. By understanding your cholesterol ratios and taking proactive steps to optimize them, you're investing in long-term cardiovascular health and overall well-being. Remember that cholesterol management is a marathon, not a sprint, and consistent healthy habits yield the best results over time.

References

  1. Millán, J., Pintó, X., Muñoz, A., Zúñiga, M., Rubiés-Prat, J., Pallardo, L. F., ... & Pedro-Botet, J. (2009). Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vascular Health and Risk Management, 5, 757-765.[PubMed]
  2. Calling, S., Johansson, S. E., Wolff, M., Sundquist, J., & Sundquist, K. (2021). The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women's health in the Lund area (WHILA): a 17-year follow-up cohort study. BMC Cardiovascular Disorders, 21(1), 1-10.[PubMed][DOI]
  3. Madsen, C. M., Varbo, A., & Nordestgaard, B. G. (2017). Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies. European Heart Journal, 38(32), 2478-2486.[PubMed][DOI]
  4. Schaefer, E. J., Anthanont, P., & Asztalos, B. F. (2014). High-density lipoprotein metabolism, composition, function, and deficiency. Current Opinion in Lipidology, 25(3), 194-199.[PubMed][DOI]
  5. Welty, F. K. (2013). Hypobetalipoproteinemia and abetalipoproteinemia. Current Opinion in Lipidology, 24(2), 119-125.[PubMed][DOI]
  6. Fernández-Friera, L., Fuster, V., López-Melgar, B., Oliva, B., García-Ruiz, J. M., Mendiguren, J., ... & Sanz, J. (2017). Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors. Journal of the American College of Cardiology, 70(24), 2979-2991.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my LDL/HDL ratio at home?

You can test your LDL/HDL ratio at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive cholesterol testing including LDL, HDL, total cholesterol, and advanced markers like ApoB and ApoA1 for a complete cardiovascular risk assessment.

What is considered a dangerously low LDL/HDL ratio?

While there's no universally defined "dangerously low" ratio, ratios below 1.0 are uncommon and may warrant investigation. Extremely low ratios could indicate genetic conditions affecting cholesterol metabolism or other underlying health issues that should be evaluated by a healthcare provider.

Can you have too much HDL cholesterol?

Yes, extremely high HDL levels (above 100 mg/dL) may not provide additional cardiovascular benefits and could indicate dysfunctional HDL particles. Very high HDL can result from genetic conditions like CETP deficiency and should be evaluated in context with other cardiovascular risk factors.

How quickly can I improve my LDL/HDL ratio?

With consistent lifestyle changes including diet modification and regular exercise, you can see improvements in your LDL/HDL ratio within 6-12 weeks. However, the degree of change varies based on genetics, baseline levels, and adherence to interventions. Regular testing every 3-6 months helps track progress.

Should I be concerned if my LDL is very low?

LDL levels below 40 mg/dL are uncommon and may indicate conditions like hypobetalipoproteinemia. While low LDL generally reduces cardiovascular risk, extremely low levels can impair absorption of fat-soluble vitamins and hormone production, warranting medical evaluation.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details